Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs
Author:
Affiliation:
1. Novartis Pharmaceuticals, San Carlos, California 94070, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00147
Reference67 articles.
1. Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
2. Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)
3. 74 Improved tolerability, adherence and reduced intravenous (IV) antibiotic usage in CF patients receiving inhaled versus nebulised antibiotic prophylaxis. A real world comparison of tobramycin inhaled powder (TIP) and tobramycin inhaled solution (TIS)
4. 68 Comparison of pharmacy prescription refill frequency in CF adults before and after switching from tobramycin inhalation solution (TIS) to TOBI Podhaler – ‘Real world’ evidence of improved adherence
5. 67 Clinical outcomes and patient satisfaction following initiation of the TOBI Podhaler in CF adults
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Novel Technique to Assess Drug Substance Particle Size in a Complex Inhaled Formulation;Journal of Pharmaceutical Sciences;2023-09
2. An evolving perspective on novel modified release drug delivery systems for inhalational therapy;Expert Opinion on Drug Delivery;2023-02-16
3. Spray freeze dried niclosamide nanocrystals embedded dry powder for high dose pulmonary delivery;Powder Technology;2023-02
4. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers;Pharmaceutical Development and Technology;2023-01-26
5. Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development;Pharmaceutics;2022-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3